The DCNN works to advance our understanding of neurodegenerative disease, with the expectation that such advances will offer opportunities for leveraging acquired mechanistic knowledge into substantive opportunities for therapy development.
 |
Andrew West, PhD Director, Duke Center for Neurodegeneration and Neurotherapeutics Professor of Pharmacology and Cancer Biology Read Dr. West’s “Profiles in Brain Sciences” interview here. |
Recent Comments